Published in Biometrics on September 01, 1994
Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis. Aliment Pharmacol Ther (2015) 1.04
Comparative trial of two intravenous doses of granisetron (1 versus 3 mg) in the prevention of chemotherapy-induced acute emesis: a double-blind, randomized, non-inferiority trial. Support Care Cancer (2011) 0.77
A randomized clinical study on postoperative pain comparing the Polysoft patch to the modified Kugel patch for transinguinal preperitoneal inguinal hernia repair. Surg Today (2015) 0.75
An ecological study on the association of public dental health activities and sociodemographic characteristics with caries prevalence in Japanese 3-year-old children. Caries Res (2006) 1.46
The detection of disease clustering in time. Biometrics (1984) 1.15
Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer (1995) 1.14
Lymphocyte subsets identified by monoclonal antibodies in healthy children. Pediatr Res (1986) 1.12
Focal area of ground-glass opacity and ground-glass opacity predominance on thin-section CT: discrimination between neoplastic and non-neoplastic lesions. Clin Radiol (2005) 0.90
Analysis of c-myc DNA amplification in non-small cell lung carcinoma in comparison with small cell lung carcinoma using polymerase chain reaction. Clin Exp Med (2001) 0.90
[Validity and reproducibility of a semi-quantitative food frequency questionnaire for nutritional education of patients of diabetes mellitus (FFQW65)]. Nihon Koshu Eisei Zasshi (2000) 0.90
Mortality experience of cockpit crewmembers from Japan Airlines. Aviat Space Environ Med (1993) 0.87
Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study. Br J Dermatol (2003) 0.87
[A statistical method for method-comparison studies--linear structural relationship considering measurement errors]. Rinsho Byori (1988) 0.87
Adjusting Moran's I for population density. Stat Med (1998) 0.86
Clinical features and course of type A and type B vitiligo. Br J Dermatol (1988) 0.85
[Studies on the operative factors affecting the reduction of chronic subdural hematoma, with special reference to the residual air in the hematoma cavity]. No Shinkei Geka (1989) 0.83
Estimation of normal ranges of clinical laboratory data. Stat Med (1986) 0.81
Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience. Vox Sang (1993) 0.80
Expression of three cell proliferation-associated antigens, DNA polymerase alpha, Ki-67 antigen and transferrin receptor in nodal and cutaneous T-cell lymphomas. Int J Hematol (1991) 0.79
Finding cases of angle-closure glaucoma in clinic setting using a newly developed instrument. Eye (Lond) (2006) 0.79
A comparative study of alteration in lymphocyte subsets among varicella, hand-foot-and-mouth disease, scarlet fever, measles, and Kawasaki disease. Microbiol Immunol (1987) 0.78
Generalized Mantel-Haenszel procedures for 2 x J tables. Environ Health Perspect (1994) 0.78
[Age and sex dependent distribution pattern and normal range of blood cell parameters obtained by automated blood cell analyzer]. Rinsho Byori (1993) 0.78
Re: Improved confidence intervals for the difference between binomial proportions based on paired data by Robert G. Newcombe, Statistics in Medicine, 17, 2635-2650 (1998) Stat Med (1999) 0.78
Rates of endometriosis recurrence and pregnancy 1 year after treatment with intranasal buserelin acetate (Suprecur) (a prospective study). J Obstet Gynaecol Res (1999) 0.77
[Maximum likelihood estimation of date of infection in an outbreak of diarrhea due to contaminated foods assuming lognormal distribution for the incubation period]. Nihon Koshu Eisei Zasshi (1998) 0.77
Physical and personality traits of preschool children in Fuzhou, China: only child vs sibling. Child Care Health Dev (2000) 0.77
Spatial clusters of Creutzfeldt-Jakob disease mortality in Japan between 1995 and 2004. Neuroepidemiology (2008) 0.76
[A quantitative study of brain atrophy on computed tomography--multivariate analysis for comparison between the linear measurement method and the pixel count method]. No To Shinkei (1985) 0.75
A quantitative study of physiological cerebral atrophy with aging. A statistical analysis of the normal range. Neuroradiology (1987) 0.75
[The normal range of cerebral atrophy during aging: statistical analysis of 500 normal subjects]. No To Shinkei (1986) 0.75
Statistical issues on the no-observed-adverse-effect level in categorical response. Environ Health Perspect (1994) 0.75
Use of screening tests to assess cancer risk and to estimate the risk of adult T-cell leukemia/lymphoma. Environ Health Perspect (1990) 0.75
[Clinical epidemiology of asthma in children. 1. Survey on allergic diseases at Oshima]. Arerugi (1983) 0.75
[11 cases of adult acute leukemia surviving more than 5 years]. Rinsho Ketsueki (1986) 0.75
[Comparative study of new method and the Kawai and Fukutomi methods for estimating excess mortality associated with influenza-epidemics, based upon national vital statistics from 1975 to 1997]. Nihon Koshu Eisei Zasshi (2001) 0.75
[Efficacy of influenza vaccination and its relationship to daily absentee rate]. Nihon Koshu Eisei Zasshi (1993) 0.75
Prediction of the development of cerebral palsy from perinatal risk factors. Brain Dev (1983) 0.75
An interpretation of normal ranges bases on individual difference quotient: extension to multivariate case. Med Inform (Lond) (1983) 0.75
Altered immune responsiveness in patients with chronic glomerulonephritis. Microbiol Immunol (1989) 0.75
[A study of the trend of mortality from cirrhosis of the liver in Japan, 1955-79]. Nihon Eiseigaku Zasshi (1984) 0.75
Re: "Statistical modelling of lung cancer and laryngeal cancer incidence in Scotland, 1960-1979". Am J Epidemiol (1988) 0.75
An interpretation of normal ranges based on a new concept "individual difference quotient" of clinical laboratory data. Med Inform (Lond) (1981) 0.75
[Prevalence of the HCV associated markers among blood donors in Japan]. Nihon Rinsho (1991) 0.75
[Normal distribution or log-normal distribution? (author's transl)]. Rinsho Byori (1979) 0.75
[A proposal for a new definition of excess mortality associated with influenza-epidemics and its estimation]. Nihon Koshu Eisei Zasshi (2001) 0.75
On the methods calculating mean survival time in 51Cr-platelet survival study. Am J Hematol (1980) 0.75
On the asymptotic distribution of Tango's clustering index. Biometrics (1986) 0.75
[Individual difference quotient of clinical laboratory data (author's transl)]. Rinsho Byori (1980) 0.75
[Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia]. Rinsho Ketsueki (1999) 0.75
[Clinical epidemiology of bronchial asthma in children report. No. III. Comparison of prevalence of asthma with 1982 and 1990 and environmental factors]. Arerugi (1992) 0.75
Confidence intervals for differences in correlated binary proportions. Stat Med (2000) 0.75
Disease clustering in time. Biometrics (1992) 0.75
[Clinical epidemiology of bronchial asthma in children report. No. II. Prognosis and house-environment]. Arerugi (1985) 0.75
[Development of Statistical Package for Medical Science, SPMS (author's transl)]. Iyodenshi To Seitai Kogaku (1980) 0.75
[Studies of the factors affecting the reduction of chronic subdural hematoma: effect of preoperative factors with special reference to cerebral atrophy]. No Shinkei Geka (1988) 0.75
[Preparation of data for based on various research--application of statistical methods]. Nihon Shokakibyo Gakkai Zasshi (1998) 0.75
Immunoglobulin levels in patients on long-term hemodialysis. N Engl J Med (1981) 0.75
A randomized controlled trial of interferon-alpha in patients with cirrhosis caused by 2a/2b genotype hepatitis C virus. J Hepatol (1998) 0.75
[Statistics on the crown prosthetic appliances in the clinical practice of students]. Nichidai Koko Kagaku (1987) 0.75
[On the proper interpretation of normal values by individual differences quotient (author's transl)]. Rinsho Byori (1981) 0.75
Cold activation of complement in sera from patients with persistent hepatitis C virus infection on interferon therapy. J Gastroenterol Hepatol (1996) 0.75